+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Insulin"

Diabetic Neuropathy - Pipeline Insight, 2026 - Product Thumbnail Image

Diabetic Neuropathy - Pipeline Insight, 2026

  • Drug Pipelines
  • May 2026
  • 180 Pages
  • Global
From
Congenital Hyperinsulinism - Pipeline Insight, 2026 - Product Thumbnail Image

Congenital Hyperinsulinism - Pipeline Insight, 2026

  • Clinical Trials
  • May 2026
  • 60 Pages
  • Global
From
Hypoglycemia - Pipeline Insight, 2026 - Product Thumbnail Image

Hypoglycemia - Pipeline Insight, 2026

  • Clinical Trials
  • April 2026
  • 180 Pages
  • Global
From
Diabetes - Pipeline Insight, 2026 - Product Thumbnail Image

Diabetes - Pipeline Insight, 2026

  • Clinical Trials
  • April 2026
  • 450 Pages
  • Global
From
Type 2 Diabetes - Pipeline Insight, 2026 - Product Thumbnail Image

Type 2 Diabetes - Pipeline Insight, 2026

  • Drug Pipelines
  • April 2026
  • 280 Pages
  • Global
From
From
From
From
From
Diabetes Therapeutics and Diagnostics - Product Thumbnail Image

Diabetes Therapeutics and Diagnostics

  • Report
  • January 2026
  • 187 Pages
  • Global
From
Lipodystrophy Syndrome Epidemiology Forecast 2026-2035 - Product Thumbnail Image

Lipodystrophy Syndrome Epidemiology Forecast 2026-2035

  • Report
  • May 2026
  • 100 Pages
  • Global
From
Prediabetes Epidemiology Forecast 2026-2035 - Product Thumbnail Image

Prediabetes Epidemiology Forecast 2026-2035

  • Report
  • May 2026
  • 100 Pages
  • Global
From
Congenital Hyperinsulinism (CHI) Drug Pipeline Analysis Report 2026 - Product Thumbnail Image

Congenital Hyperinsulinism (CHI) Drug Pipeline Analysis Report 2026

  • Drug Pipelines
  • May 2026
  • 150 Pages
  • Global
From
Hypertriglyceridemia Drug Pipeline Analysis Report 2026 - Product Thumbnail Image

Hypertriglyceridemia Drug Pipeline Analysis Report 2026

  • Drug Pipelines
  • May 2026
  • 150 Pages
  • Global
From
From
Diabetic Hypoglycemia Epidemiology Forecast 2025-2034 - Product Thumbnail Image

Diabetic Hypoglycemia Epidemiology Forecast 2025-2034

  • Report
  • March 2026
  • 150 Pages
  • Global
From
From
From
Insulin Delivery Systems - Global Strategic Business Report - Product Thumbnail Image

Insulin Delivery Systems - Global Strategic Business Report

  • Report
  • August 2026
  • 272 Pages
  • Global
From
Insulin Pen Needles - Global Strategic Business Report - Product Thumbnail Image

Insulin Pen Needles - Global Strategic Business Report

  • Report
  • August 2026
  • 193 Pages
  • Global
From
Loading Indicator

The insulin market is a subset of the larger endocrine and metabolic disorders drugs market. Insulin is a hormone produced by the pancreas that helps regulate the body's blood sugar levels. It is used to treat diabetes, a condition in which the body does not produce enough insulin or is unable to use it effectively. Insulin is available in both short-acting and long-acting forms, and is typically administered via injection or an insulin pump. The insulin market is highly competitive, with a number of major pharmaceutical companies offering a variety of insulin products. These include Eli Lilly, Novo Nordisk, Sanofi, and Merck. Additionally, there are a number of smaller companies that specialize in the production of insulin, such as Biocon, Wockhardt, and Wockhardt USA. Show Less Read more